A Crossover Study to Evaluate Pegilodecakin (LY3500518) in Healthy Participants

Clinical trial NCT04194892 · COMPLETED

Trial details

NCT number: NCT04194892
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Subjects

Start date: 2018-01-19
Primary completion: 2018-03-14
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.